The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause-Reference-Cited by-同舟云学术

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

Published:2011-09-04 Issue:1 Volume:131 Page:295-306
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Chirgwin Jacquie, ,Sun Zhuoxin,Smith Ian,Price Karen N.,Thürlimann Beat,Ejlertsen Bent,Bonnefoi Hervé,Regan Meredith M.,Goldhirsch Aron,Coates Alan S.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-011-1741-6.pdf

Reference26 articles.

1. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ, Panel members (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 20:1319–1329

2. Nelson LR, Bulun SE (2001) Estrogen production and action. J Am Acad Dermatol 45(Suppl 3):S116–S124

3. Lonning PE (1996) Pharmacology of new aromatase inhibitors. Breast 5:202–208

4. Smith IE, Dowsett M, Yap Y-S, Walsh G, Lonning PE, Santen R (2006) Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea; caution and suggested guidelines. J Clin Oncol 24:2444–2447

5. Hargis JB, Nakajima ST (2006) Resumption of menses with initiation of letrozole after five years of amenorrhea on tamoxifen: caution needed when using tamoxifen followed by aromatase inhibitors. Cancer Invest 24:174–177

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to Klar and Adams;JNCI: Journal of the National Cancer Institute;2021-08-16

2. Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients;JNCI: Journal of the National Cancer Institute;2021-06-08

3. Selection of Adjuvant Endocrine Therapy for Women With Breast Cancer in Menopausal Transition: Is It Simpler Than We Thought?;JNCI: Journal of the National Cancer Institute;2021-06-08

4. Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With Letrozole;Journal of Clinical Oncology;2016-05-10

5. Tamoxifen (Selective Estrogen-Receptor Modulators) and Aromatase Inhibitors as Potential Perioperative Thrombotic Risk Factors in Free Flap Breast Reconstruction;Plastic and Reconstructive Surgery;2015-04